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A B S T R A C T The potential role ofepidermal growth
factor (EGF) in the regulation of rat liver regeneration
was examined by assessing the binding of 1251-EGF
to hepatic membranes isolated at various times after
partial hepatectomy. The results demonstrated a fall in
125I-EGF binding detectable as early as 8 h after partial
hepatectomy. The nadir in EGF binding, <40% of that
observed in sham-operated control rats, was seen 36
and 48 h after partial hepatectomy. Scatchard analysis
showed that the decrease in binding capacity was due
to a fall in receptor number. The specificity of the ob-
served loss of EGF receptors was substantiated in
parallel studies of 125j-insulin and 125I-wheat germ
lectin binding; the binding of these ligands did not
decrease appreciably during liver regeneration. The
data are consistent with the hypothesis that EGF or a
similar substance is one component of the complex
humoral signal that regulates liver regeneration.
INTRODUCTION
Advances in cell and organ culture techniques have
led to the identification of numerous serum and cell-
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derived growth factors (1). The effect of these factors
on proliferation and differentiation has been amply
demonstrated in vitro, but their role in physiologic
control of growth in vivo is largely undefined. Spe-
cifically, epidermal growth factor (EGF),I a well-
studied mitogen (2), stimulates rat hepatic DNA synthe-
sis both in vitro (3) and in vivo (4). However, there
is no evidence demonstrating that EGF is involved in
the regulation of the hepatocyte proliferation that
rapidly and reproducibly follows partial hepatectomy.
The present study examined the potential relationship
between EGF and liver regeneration indirectly by
determining the binding of 1251-EGF to liver mem-
branes at various times after partial hepatectomy and
sham-operation. This approach was predicated upon
the well-studied "down regulation" of EGF receptor
number that attends cellular stimulation by EGF (2).
METHODS
Male Sprague-Dawley rats from Charles River Breeding
Laboratories, Wilmington, Mass. (150-175 g) were fed and
watered ad lib. pre- and postoperatively. Under ether anes-
thesia the median and left hepatic lobes were extruded
and either excised (66-70% hepatectomy) or returned to
the peritoneal cavity (sham-operation). Operations were
performed at various times so that all rats in an experiment
were killed between 8 and 9 a. m. Livers were homogenized
in 0.25 M sucrose-10mM Tris-HCl (pH 8.0) with a Brinkmann
polytron apparatus (setting of 5, 20 s) Brinkmann Instruments,
Westbury, N. Y.). Homogenates were centrifuged at 12,000 g,
' Abbreviation used in this paper: EGF, epidermal growth
factor.
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and the microsomal fraction was subsequently pelleted by
centrifuging the supernate at 105,000 g (1 h, 50 Ti Rotor).
Purified plasma membrane fractions were prepared by the
method of Touster et al. (5) and the purity assessed by assay
of 5'-nucleotidase activity (6).
Binding studies. Mouse EGF was purified to homogeneity
(7) and iodinated with carrier-free Na'251 (Union Carbide
Corp., South Plainfield, N. J.) to a specific activity of 1.2
Ci/,smol (8). Na'251 was removed by chromatography on
Sephadex G-25 in 0.1 M sodium phosphate - 0.1% bovine
serum albumin, pH 7.5. Radio-labeled ligands were incubated
with 9-25 ug membrane protein (9) for 40 min at 24°C in
0.2 ml Dulbecco's phosphate-buffered saline containing 0.1%
bovine serum albumin. Duplicate samples were collected on
Millipore EGWP filters (Millipore Corp., Bedford, Mass.)
(10). Each determination was corrected for nonspecific bind-
ing by subtraction of 1251-ligand bound in the presence of
1 ,uM native ligand added 10 min prior to the labeled ma-
terial. Porcine insulin (Eli Lilly & Co., Indianapolis, Ind.)
and wheat germ agglutinin (Calbiochem-Behring Corp., San
Diego, Calif.) were iodinated in a similar fashion (600 and 450
Ci/mmol, respectively). The assay concentration of all three
labeled ligands was 2-5 nM.
RESULTS
Fig. 1 depicts the results of experiments in which
the membrane binding of 1251-EGF was assessed
after partial hepatectomy or sham-operation. The com-
parison indicates that a fall in EGF binding capacity
is detected by 8 h and progresses during the initial
36 h. Since the onset of DNA synthesis occurs - 16 h
after partial hepatectomy (11), the decrease in EGF
binding precedes the onset ofDNA synthesis. Examina-
tion of EGF binding in sham-operated rats at 8, 16,
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FIGURE 1 EGF binding to hepatic microsomal membranes
during liver regeneration. The specific 1251-EGF binding at the
indicated times following partial hepatectomy is expressed as
the percent binding ofthe matched sham-operated and control
rats. The height of the bar represents the mean of n separate
observations. The brackets represents the range when
n = 2 and the SEM when the n = 4-6. The level of sig-
nificance was determined in the latter by analysis of variance.
*P < 0.01. **P < 0.02.
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FIGURE 2 Specific 125I-EGF binding at various ligand con-
centrations. Microsomal membranes (24 ,ug protein) prepared
from sham-operated (0) and regenerating (a) rat livers 24 h
after surgery were used. Scatchard analysis by linear regres-
sion in this and two similar experiments showed that the de-
crease in binding capacity was due to a fall in receptor
number.
from 95-110% that observed in unoperated control
rats; therefore, the operative stress itself does not alter
EGF binding.
Fig. 2 shows the binding of 1251-EGF at various
concentrations in membranes prepared simultaneously
from rats 24 h after sham-operation and partial hepatec-
tomy. Scatchard analysis by linear regression indicates
that the difference in binding capacity is produced by
a 50% reduction in receptor number; the calculated
binding constants, 1.7 and 1.4 nM (sham and regenerat-
ing), are equivalent.
To determine whether a general decrease in hor-
mone receptor or membrane glycoprotein synthesis oc-
curred during the growth process, the binding of two
other 125I-labeled ligands was assessed 36 h after partial
hepatectomy and sham-operation. The binding of
1251-insulin was increased slightly (Table I). Insulin
concentrations fall during regeneration (12) and the
slightly increased insulin binding may reflect the de-
TABLE I
Ligand Binding during Regeneration
'125I-Ligand Binding n P
EGF 37+11 4 <0.02
Insulin 134+38 4 NS
Wheat germ agglutinin 99±+13 4 NS
The binding of'25I-labeled ligands to membranes isolated 36 h
after partial hepatectomy and sham-operation. The cumulative
percent change (mean± SEM) in ligand binding (regenerating/
sham-operation) in the four separate experiments in which the
binding of all three ligands was studied is shown.
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crease in portal vein insulin concentration. The binding
of 125I-wheat germ agglutinin was determined to assess
membrane glycoprotein content. (The EGF receptor
appears to be a glycoprotein [2]). Lectin binding was
equivalent in sham and regenerating liver membranes
(Table I).
The binding of 125I-EGF in microsomal and purified
plasma membrane fractions was compared to deter-
mine whether the decrease was confined to a loss of
plasma membrane receptors. The EGF binding capac-
ity (per microgram protein) of plasma membranes
from both sham and regenerating livers was increased
proportionally (8-10-fold) when compared with micro-
somal preparations from the same livers. Thus, the
"down regulation" of 125I-EGF binding during re-
generation was observed when purified plasma mem-
brane fractions were examined; again there was no de-
crease in insulin or lectin binding (data not shown).
A 20-fold increase in the specific activity of 5'-nucleo-
tidase above that found in homogenates confirmed the
purity of the plasma membrane preparations.
DISCUSSION
Experiments utilizing cultured cells have demon-
strated that one consequence of EGF binding is the
loss of cell-surface EGF receptors (2) and internaliza-
tion ofthe EGF-receptor complex (13). In homogeneous
cultured cell populations, the fall in EGF receptor
number may approach 90%, but the mitogenic action
has been demonstrated at lower receptor occupancy
(14). During regeneration the maximum fall was 65%.
This may reflect the heterogeneous cell population or
the fact that 100% receptor occupancy is unnecessary
for the proliferative response.
It is unclear whether receptor loss and/or internaliza-
tion are obligatory steps in the mitogenic response;
however, in the absence of pharmacologic perturba-
tion, these events follow EGF binding and, conversely,
may reflect EGF action. A simple explanation of the
present data is that partial hepatectomy increases
plasma EGF concentration, which leads to "down
regulation." The putative increase in plasma EGF
might be effected by a regulated release of EGF
or, alternatively, since two-thirds of the liver has
been removed, a decrease in the degradation of
EGF may result in elevation of the concentration
perfusing the liver remnant. Several alternative
explanations must be considered. These include (a)
the stimulation of hepatocytes by other humoral fac-
tors that may bind to the EGF receptor and trigger
its internalization (15), (b) a modulation in apparent
receptor number produced by hormones (16) or factors
(17) that do not bind directly to the EGF receptor, (c)
an intracellular process that results in the loss of
EGF receptors. The latter possibility might occur as a
consequence of growth and has been suggested as a
mechanism underlying certain types of viral trans-
formation (18).
Liver regeneration clearly provides an in vivo model
of proliferation in which to study the "down regula-
tion" ofEGF receptor number. Resolution ofthe mech-
anism of receptor loss awaits further research in-
cluding accurate measurement ofEGF plasma concen-
tration. However, since exogenous EGF leads to DNA
synthesis (3, 4) and lipid accumulation (19), two phe-
nomena that occur during regeneration, it is tenta-
tively concluded that EGF binding to specific receptors
plays a physiologic role in the complex response to
partial hepatectomy.
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